Results 141 to 150 of about 4,255 (159)

[Chinese expert consensus on the diagnosis and treatment of human immunodeficiency virus infection related diffuse large B cell lymphoma (2025)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Lymphoid Disease Group   +5 more
europepmc   +1 more source

[Clinical efficacy and safety of rituximab in treating renal injury in primary Sjögren syndrome]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban
Zhao Y   +6 more
europepmc   +1 more source

[The guideline for the diagnosis and treatment of marginal zone lymphoma in China (2025)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Hematological Oncology Committee of China Anti-Cancer Association   +5 more
europepmc   +1 more source

[Effect of phenytoin and levetiracetam on busulfan blood concentration in children undergoing hematopoietic stem cell transplantation]. [PDF]

open access: yesZhongguo Dang Dai Er Ke Za Zhi
Xu SX   +8 more
europepmc   +1 more source

[<i>Lactobacillus plantarum</i> ZG03 alleviates oxidative stress <i>via</i> its metabolites short-chain fatty acids]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao
Lin S   +8 more
europepmc   +1 more source

[LncRNA Meg3 expression level is negatively correlated with liver fibrosis severity in patients with Wilson disease]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao
Hua D   +8 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

乙型肝炎病毒感染对复发难治性弥漫大B细胞淋巴瘤疗效及预后的影响

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2018
目的 研究乙型肝炎病毒(HBV)感染对复发难治性弥漫大B细胞淋巴瘤(DLBCL)的疗效及预后的影响。 方法 回顾性分析2004年1月至2016年11月81例复发难治性DLBCL患者,根据乙型肝炎表面抗原(HBsAg)的情况将患者分为HBsAg阳性和HBsAg阴性两组,比较两组患者的临床特征、疗效和预后。 结果 全部81例复发难治性DLBCL患者中,HBsAg阳性患者24例(29.6%),HBsAg阴性患者57例(70.4%)。相较于HBsAg阴性组,HBsAg阳性组年轻患者更多(P=0.005)、Ann
Y. Fang, Li Wang, Y. Qian, Wei Zhao
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy